- A to Z Drug List
- Treatment Options
- Drugs by Class
- Side Effects
- Medical Q & A
- Generic Drugs
- Harvard Health Guide
- Mayo Clinic Disease Reference
- Phonetic Search
- Pregnancy Warnings
- OTC Database
- Inactive Ingredients
- Veterinary Drugs
- International Drugs
- Info en Español
- Pricing & Coupon Guide
- Interactions Checker
- Pill Identifier
- Symptom Checker
- Medication Record
- Mobile Apps
- Drug Imprint Codes
- Community Support
- Compare Drugs
News & Alerts
- Medical News
- Clinical Trial Results
- FDA Drug Alerts
- FDA Consumer Updates
- New FDA Approvals
- New Drug Applications
- Drug Shortages
- Video Center
- Popular Articles
- Health & Medication Slideshows
Top 100 Drugs
- Plan B
Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
Young Adults, Children With Overweight Have Higher Risk for VTE in Adulthood
Young adult and childhood overweight are determinants of the risk for venous thromboembolic events (VTE) in adult men, according to a study published online...
Do Sweat It: Could 'Body Odor Therapy' Ease Anxiety?
Could inhaling a deep whiff of another person’s sweat help ease crippling social anxiety? Quite possibly, new Swedish research suggests. The notion...
Healthy Relationships Could Bring Healthier Bodies, Study Shows
Close relationships -- and whether your experiences within those relationships are positive or negative -- could influence your physical health. New research...
FDA Approves Joenja (leniolisib) for the Treatment of Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS)
Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces that the US Food and Drug Administration (FDA) has...
Used After Opioid Overdose, Anti-Addiction Drug Can Cut Odds for Fatal OD
When someone lives through an opioid overdose, taking the medication buprenorphine lowers their risk of death if they OD again, according to new research. Buprenorphine...
New Drug Combo Buys More Time for Advanced Endometrial Cancer Patients
Researchers have discovered that two drugs might be better than one for women who have advanced endometrial cancer. Combining chemotherapy and immunotherapy...
Trial Results for Ovarian Cancer will lead to new Standard of Care
MIAMI BEACH, Fla., March 28, 2023. Mount Sinai Medical Center (MSMC) is pleased to announce the results of a clinical trial led by Brian Slomovitz, MD,...
NIH Researchers Discover New Autoinflammatory Disease, Suggest Target for Potential Treatments
Scientists have identified an autoinflammatory disease caused by mutations in the LYN gene, an important regulator of immune responses in health and disease....
Regeneron and Sonoma Biotherapeutics Announce Collaboration to Discover, Develop and Commercialize Treg Cell Therapies for Autoimmune Diseases
TARRYTOWN, N.Y., and SOUTH SAN FRANCISCO, Calif., March 28, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sonoma Biotherapeutics,...
AAD: Long-Term Improvement Seen With Ruxolitinib in Vitiligo
For patients with nonsegmental vitiligo, continued improvement in seen during a long-term extension of ruxolitinib treatment, according to study presented...
MI Risk Increased With Subclinical, Obstructive Coronary Atherosclerosis
Subclinical, obstructive coronary atherosclerosis is associated with increased risk for myocardial infarction in asymptomatic persons aged 40 years and...
4.7 Percent of Students With Disabilities Experience Homelessness
Overall, 4.7 percent of students with disabilities experience homelessness across seven states and Washington D.C., according to a study published online...
Risk of Developing Osteoarthritis Increased for Patients With Atopic Disease
Patients with atopic disease have an increased risk of developing osteoarthritis (OA), according to a study published online March 27 in the Annals of...
Hypertension in Teens Tied to Heart Damage
Hypertension may precede premature cardiac damage in young adults, according to a study published online March 2 in The Journal of Pediatrics. Andrew...
Endogenous Ghrelin Tied to Weight Gain in Patients With Anorexia
Endogenous ghrelin is associated with longitudinal weight gain in girls and young women with anorexia nervosa, according to a study published online March...
Hydroxyurea Underused in Youth With Sickle Cell
Few youths with sickle cell anemia (SCA) receive hydroxyurea despite national guidelines recommending its use, according to a study published online March...
Older Adults With Food Insecurity Face Faster Decline in Executive Function
Food insecurity is common among community-dwelling older adults and is associated with a decline in executive function, according to a study published...
Marriage, Children Tied to Earnings Penalty for Female Physicians
Being married with children is associated with a greater earnings penalty for female physicians, according to a study published online March 24 in JAMA...
Daily Step Counts Declined With Onset of Pandemic
Following onset of COVID-19, there was a decrease in activity, represented by a reduction in daily step counts, according to a research letter published...
Adverse Postoperative Outcomes Not Increased With Recent COVID-19
Recent COVID-19 infection seems not to be associated with the risk for adverse postoperative outcomes, according to a research letter published online...
Recently added consumer and prescribing information: Joenja, Rezzayo, Zynyz, Daybue, Zavzpret, Combogesic, Skyclarys, Filspari, Jaypirca, Brenzavvy
- Cerner Multum Drug Information
- IBM Watson Micromedex Advanced Consumer
- Natural Product Information for the Consumer
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- IBM Watson Micromedex Carenotes
- Natural Product Information
Latest FDA New Drug Approvals
- Joenja Joenja (leniolisib) is a kinase inhibitor indicated for the treatment of activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS)...
- Rezzayo Rezzayo (rezafungin) is an echinocandin antifungal used for the treatment of candidemia and invasive candidiasis.
- Zynyz Zynyz (retifanlimab-dlwr) is a programmed death receptor-1 (PD-1)-blocking antibody for the treatment of Merkel cell carcinoma.
Drugs in Development (Not yet approved)
- Lumryz Lumryz (sodium oxybate) is a once-nightly formulation of the approved central nervous system depressant sodium oxybate in development for...
- Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...
- Libervant Libervant (diazepam) is a buccal film formulation of the approved benzodiazepine diazepam in development for the management of seizure clusters.